baber/WOPTO huggingface dataset:
Patent JP-2000506319-A (JP)
Title: ストリップレーザー
IPC: H01S3/03
Filed: 1997-02-08
Abstract: (57)【要約】
この発明は、２つの平らな電極（２，３）の間に放電空間（４）を有するストリップレーザーに関する。この発明によれば、共振器内部のフォールディングミラー装置（１６、２０；３０、３４）を有する平らな、放電空間（４）の幅（ｂ）に関して安定なマルチパスー共振器（８、１２、１６、２０；８、１２、３０、３４）が、放電空間の長手方向に対して垂直に向けた端面（４２、４４）に配置されている。
Patent JP-2001519762-A (JP)
Title: Ｔリンパ球への巨大分子プロドラッグのターゲティング
IPC: A61K47/48
Filed: 1997-03-12
Abstract: (57)【要約】
化学作用因子のＴ細胞への細胞内送達のための組成物は、受容体−結合および飲食作用誘導リガンドおよび水溶性重合体に結合した化学作用因子を含む。このリガンドはＴリンパ球上の受容体に結合して上記組成物の飲食作用を導き出す。該組成物はまた化学作用因子及びリガンドを重合体に結合するためのスペーサーも含む。化学作用因子は細胞毒素、形質転換核酸、遺伝子調節因子、標識、抗原薬物等であり得る。好適水溶性重合体はＮ−（２−ヒドロキシプロピル）メタクリルアミド（ＨＰＭＡ）の共重合体である。上記組成物はまた水溶性重合体、リポソームまたは粒状物のようなキャリアーを含むこともできる。これらの組成物を使用して化学作用因子をインビボおよびインビトロで送達する方法も開示されている。
Patent JP-H11511919-A (JP)
Title: 逆インターｍｓｃハンドオーバ
IPC: H04W36/12
Filed: 1996-12-17
Abstract: (57)【要約】
ＧＳＭシステムは、失われた呼を再確立するためのプロトコルを含む。インターＭＳＣ（ＭＳＣ−Ａ、ＭＳＣ−Ｂ）ハンドオーバの後に呼が失われると問題が生ずる。すなわち、そのシステムは、移動ステーション（ＭＳ）の加入者データがどのＭＳＣへ更新されたかを知らない。もし、ＭＳＣがその呼の間に変わって、そのＭＳが元のＭＳＣ−Ａによってサービスされたセルにもはやコンタクトできない場合には、その呼は、失われてしまうであろう。本発明による方法では、移動ステーションの位置領域にサービスしているＭＳＣは、その移動ステーションによって送信され且つその移動ステーションの直前位置領域識別子を含むスタートメッセージ（１′）を検出する。その直前位置領域識別子に基づいて、第２の移動交換センターＭＳＣ−Ｂは、スタートメッセージ（１′）を検出し、どの領域の第１の移動交換センターＭＳＣ−Ａがその呼を開始したのかを決定する。これに続いて、第２の移動交換センターＭＳＣ−Ｂは、第１の移動交換センターＭＳＣ−Ａへの接続を確立しうる。この段階で、移動交換センター（ＭＳＣ−ＡおよびＭＳＣ−Ｂ）は、その役割を交代し、この方法は、通常のインターＭＳＣハンドオーバにおけるのと同じように進められる。接続を確立するための本発明の方法は、ＧＳＭシステムネットワーク構造を使用するサテライトシステムにも適用されうる。
Patent JP-2002513511-A (JP)
Title: 電磁気応用のためのヴァイアの無い集積誘導性素子
IPC: H01F17/00
Filed: 1998-01-30
Abstract: (57)【要約】
ヴァイアに対する必要性無しで磁気コアの回りに巻かれる導電性コイル(６０、６２)生成するよう、導体材料(３２)、隔離材料(３４)、コア材料(５０)、隔離材料（５２）及び導体材料（５４）の層の沈積及びパターン化を含む電極鋳造法により、ＶＬＳＩ回路及びデバイスにおける集積化に適切なインダクタが製造される。製造段階は、ミクロ電子工学技術及びミクロ機械加工技術の組合せを用いる。
Patent JP-2002529047-A (JP)
IPC: C22B21/06
Filed: 1997-12-09
Abstract: In order to separate metals and/or metal alloys of different melting points from one another, a mixture of these metals and/or metal alloys is brought to a temperature at which the metal or the metal alloy of relatively low melting point is molten and the metal or the metal alloy of relatively high melting point is in the solid state. The solid constituents are separated from the melt, use being made of washing column with at least one filter which withstands the temperature of molten metal. Each of the filters is arranged in the wall of a separate pipe which extends through the washing column. The mixture is fed to one end of the washing column and moves along the pipe or pipes, towards means arranged at the opposite side of the washing column for removing solid crystalline material. The melt passes via the filter or filters into the pipe or pipes, and flows in countercurrent to the mixture situated on the outside of the pipe or pipes, towards a melt discharge. A suspension zone situated in an upper part of the washing column changes into a packed bed of crystals. At the bottom of the washing column, the crystals are washed in countercurrent with their own recirculated melt.
Patent JP-H11505894-A (JP)
Title: 開口直列配置型織機の緯糸分配装置
IPC: D03D41/00
Filed: 1996-04-26
Abstract: (57)【要約】
本発明は、開口直列配置型織機における緯糸分配装置に関し、同装置において、緯糸（９）は供給ノズル（１）を介して連結通路（３）に供給されるとともに連結通路内にて導入管（４，４’）に分配される。挿入された緯糸をスムーズに切断し、新たな緯糸の端部が再分配されるために、切断装置（５）は、導入管（４）及び狭持装置（６）の間にて空間的に固定されており、それにより、引き込み力（１５）及び同引き込み力（１５）の影響下にあるループ（１９）は、狭持装置（６）にて緯糸が停止する前に、供給ノズル（１）及び補助ノズル（２）にて既に形成される。狭持装置（６）において静止している間、糸は切断装置（５）中にて予め緊張状態が保たれ、容易に切断され得る。ループ（１９）が自身で解かれ、新たな緯糸の端部が導入管（４’）中へ挿入される。
Patent JP-2001513236-A (JP)
IPC: G05B9/03
Filed: 1998-02-13
Abstract: An at least dual-channel homogeneous-redundancy-based electronic device, preferably a dual-channel homogeneous-redundancy-based central processing unit of a stored-program control, that has at least one certified channel and at least one non-certified channel. The at least one, and certified channel is a channel that is sufficiently free of systematic errors. Components that have not been proven sufficiently free of systematic errors can be used in the at least one non-certified channel.
Patent JP-2000513741-A (JP)
IPC: A61P17/02
Filed: 1998-03-02
Abstract: Methods are presented for treatment in eliminating or reducing the appearance of scar tissue by administration of streptolysin O.
Patent JP-2001516302-A (JP)
IPC: B60R21/34
Filed: 1998-03-06
Abstract: The present invention provides a restraining system (2) for an axle mounted wheel (4) of a vehicle, the vehicle having a frame (14) to which the axle (7) is secured, leaving sufficient clearance to avoid road hazards and not interfere with the wheels (4) motion during normal operation of the vehicle. The system (2) comprises a cage (10) assembly secured to the frame (14) in the vicinity of the vehicle so as to leave a lower part of the wheel (4) exposed, allowing the wheel (4) to contact the road and to retain the wheel (4) in close proximity to its original installation point and entrap the wheel (4) and carry it along with the vehicle should it become detached from the axle (7).
Patent JP-2001506320-A (JP)
Title: 非蒸発ゲッターを製造する方法及びこの方法で製造したゲッター
IPC: B22F/
Filed: 1998-03-26
Abstract: (57)【要約】
Ｚｒ及びＴｉから選択した少なくとも一つの第１の元素と、Ｖ、Ｃｒ、Ｍｎ及びＮｉの中から選択した少なくとも一つの第２の元素とを含んで成る多孔質の蒸発しないゲッター材料の製造方法を記載する。出発金属粉末は、相当酸化物を水素化カルシウムで還元することで製造し、そして得られた粉末を加圧成形して所定の範囲の温度と圧力とで焼結する。また、機械的性質とガス吸着性質との改良された組み合わせとなり、本製造方法によるゲッター本体全体に渡って化学組成が新規の分布を備えるゲッター材料を記載する。
Patent JP-2001524951-A (JP)
Title: 炎症性腸疾患を治療するための方法および組成物
IPC: A61K31/497
Filed: 1998-04-01
Abstract: (57)【要約】
本発明は、炎症性腸疾患を治療するために用いられる薬物療法の方法および組成物を提供する。本発明はさらに、非定型マイコバクテリアに対して有効な抗非定型マイコバクテリア薬の組み合わせを提供する。また、非病原性マイコバクテリアの抽出物を用いて患者を免疫することによって、炎症性腸疾患の治療における抗非定型マイコバクテリア薬の効力を高める方法も提供する。
Patent JP-2001520782-A (JP)
Title: 記憶素子および方法
IPC: G11C7/10
Filed: 1999-02-16
Abstract: (57)【要約】
継続的な画像データを順々に記憶し、その記憶した画像データを出力するための記憶素子。この記憶素子は、個々別々に機能することの出来るＮ個のメモリブロックを含む記憶ユニットと、この記憶ユニットの中に書込むための書込みアドレス信号を生成する書込みアドレスジェネレータと、この記憶ユニットから読出すための読出しアドレス信号を生成する読出しアドレスジェネレータとを含む。この記憶素子はさらに、各画像データの書込みおよび読出しの各開始アドレスをメモリブロック単位でシフトさせて書込み動作と読出し動作とが同じメモリブロックに対して同時に行われることの無いように書込みアドレス信号と読出しアドレス信号とを制御するためのコントローラを含む。この際、各画像データは、Ｍ個のブロック（Ｍ＜Ｎ）の１つに等しいサイズを有している。
Patent JP-2001521594-A (JP)
IPC: E04B2/02
Filed: 1998-04-02
Abstract: Building system comprising individual building elements (1), each element having an upper and a lower surface which are substantially parallel to each other and each building element having at least one opening (10, 11) extending from the upper surface to the lower surface, the building elements being such that they can be positioned on top of each other so that openings of different elements are aligned with respect to each other, characterized in that in each opening a connecting element (30) can be placed by means of which the building element belonging to it can be connected with a predetermined pressure to the building element located immediately below the first building element.
Patent JP-2001520560-A (JP)
Title: 超音波処理用浸水システム
IPC: A61N7/00
Filed: 1998-04-16
Abstract: (57)【要約】
本発明の超音波供給システムは超音波を用いて損傷を治療するのに使用される。本発明の超音波供給システムは人間光学的に構成された超音波変換器処理用ヘッドモジュールと主要作用ユニットとを含んでいる。変換器処理用ヘッドモジュールは損傷部の領域に隣接して位置決めされ、所定の期間にわたって励起される。本発明の超音波供給システムは、患者の体の一部を包むバスタブ用挿入部と、患者の体と隣接した位置で処理用ヘッドモジュールを位置決めして保持するための挿入部にある手段とを有している。
Patent JP-2001527661-A (JP)
Title: 冗長記憶キャパシタ構造を有する電気光学ディスプレイ
IPC: G02F1/136
Filed: 1999-02-01
Abstract: (57)【要約】
画素のマトリクスアレイと各画素に組み合わされた記憶キャパシタの薄膜構造体とを有する電気光学ディスプレイデバイス。このデバイスは、そのキャパシタプレートの一方を２つのプレートに分割して直列の２つのキャパシタをつくることによって、その記憶キャパシタ構造体に冗長性が与えられる。この分割されたプレートは、全てその薄膜構造体の１つの階層上にあるので、マスキング工程を追加する必要がない。
Patent MX-153431-A (MX)
Inventor: NELSON CALVIN G
IPC: H01R13/703
Filed: 1982-07-25
Abstract: A patch or access module usable with an insertable patch plug having a plurality of electrical contact elements. The patch or access module includes a circuit board, a first electrical circuit electrically connected with a first point on the circuit board, a second electrical circuit electrically connected with the second point on the circuit board and switch contact means for selectively making electrical connection between the first point and the second point and for making electrical connection between the first point and the electrical contact elements of the patch plug upon insertion of the patch plug into the patch or access module. The switch contact mechanism includes a first portion electrically engaged with the first point, a second portion adapted for selective electrical engagement with the second point and a third portion adapted for limited movement relative to the circuit board for electrical engagement with the electrical contact element of the patch plug when the plug is inserted into the patch module.
Patent NZ-199051-A (NZ)
Title: Castor:twin wheels with hollow load bearing spigots which engage a central body part and carry a wheel connecting element
Inventor: SCREEN S T
IPC: B60B33/00
Filed: 1981-11-24
Abstract: The load is transmitted from the body to respective hollow spigots (23) of the wheels by a bearing sleeve (22) disposed within a bearing opening of the body and the co-axial relation of the wheels is maintained primarily by a further sleeve (24) disposed within the spigots of the wheels.
Patent NZ-204933-A (NZ)
Title: Aphidicolin derivatives and pharmaceutical compositions
Inventor: RATCLIFFE A H
IPC: C07C309/65
Filed: 1983-07-18
Abstract: Aphidicolane derivatives of the formula:  <IMAGE>  wherein R1 stands for hydrogen or a hydroxy radical, R2 stands for a hydroxy or methyl radical, or the group CR1R2 stands for a keto group; R3 stands for a formyl or hydroxymethyl radical, or for the group -CH2O.CO.OR6, wherein R6 stands for a defined radical or R2 and R3 are joined together to form the group -O.CO.OCH2-; R4 stands for a hydroxy radical; R5 stands for a formyl radical, a hydroxyalkyl radical -(CH2)1-3OH, a radical -CHR7OH, wherein R7 stands for a defined radical, or R5 stands for an azidomethyl or pyrrolidinylcarbonyloxymethyl radical, or for the group -CH2O.CO.OR8, wherein R8 stands for a defined radical, or R5 stands for the group -CH2O.CO.(CH2)m.CR11R12.(CH2)n.NR9R10, wherein m, n, R9, R10, R11 and R12 have defined values, or R5 stands for the group -CH2O.SO2.R13, wherein R13 stands for a defined radical; or R4 and R5 are joined together to form the group -O.CH2- or -O.CO.OCH2-; and, where appropriate, pharmaceutically-acceptable salts thereof. Processes for the preparation of said aphidicolane derivatives. Pharmaceutical compositions comprising one of the compounds and a pharmaceutical diluent or carrier. The compounds exhibit inhibitory activity against DNA-containing viruses and they inhibit the growth of some tumors.
Patent NZ-205472-A (NZ)
Title: 1,4-dihydropyridine derivatives and pharmaceutical compositions
Inventor: CAMPBELL S F
IPC: C07D407/12
Filed: 1983-09-02
Abstract: 1,4-Dihydropyridine derivatives of the formula:-and their pharmaceutically acceptable acid addition salts; whereR is aryl or heteroaryl;R<sup>1</sup> and R<sup>2</sup> are each independently C<sub>1</sub>-C<sub>4</sub> alkyl or 2-methoxyethyl;Y is -(CH<sub>2</sub>)<sub>2</sub>-, -(CH<sub>2</sub>)<sub>3</sub>-, -CH<sub>2</sub>CH(CH<sub>3</sub>)- or -CH<sub>2</sub>C(CH<sub>3</sub>)<sub>2</sub>-;R<sup>3</sup> is hydrogen or a group selected from:-where R<sup>4</sup> is H, C<sub>1</sub>-C<sub>4</sub> alkyl, C<sub>3</sub>-C<sub>6</sub> cycloalkyl, -COO(C<sub>1</sub>-C<sub>4</sub> alkyl), -CH<sub>2</sub>COO(C<sub>1</sub>-C<sub>4</sub> alkyl), aryl, -S0<sub>2</sub>.aryl, or heteroaryl, and X is 0 or S;where R<sup>5</sup> is 1-pyrrolidinyl, -NH<sub>2</sub>, -NH(C<sub>1</sub>-C<sub>4</sub> alkyl), -N/C<sub>1</sub>-C<sub>4</sub> alkyl)<sub>2</sub>, or -NH(CH<sub>2</sub>)<sub>2</sub>N(C<sub>1</sub>-C<sub>4</sub> alkyl)<sub>2</sub>;where R<sup>6</sup> is C<sub>1</sub>-C<sub>4</sub> alkyl or aryl;where R<sup>7</sup> is -CONH(C<sub>1</sub>-C<sub>4</sub> alkyl) or -COO(C<sub>1</sub>-C<sub>4</sub> alkyl);where R<sup>8</sup> is -CN, -SO<sub>2</sub>(C<sub>1</sub>-C<sub>4</sub> alkyl) or -SO<sub>2</sub> aryl;(h) -CH<sub>2</sub>CO.R<sup>9</sup> where R<sup>9</sup> is -NH<sub>2</sub>, -NH(C<sub>1</sub>-C<sub>4</sub> alkyl), -NH.aryl or C<sub>1</sub>-C<sub>4</sub> alkoxy;(i) -SO<sub>2</sub>.R<sup>10</sup> where R<sup>10</sup> is -NH<sub>2</sub>, -N(C<sub>1</sub>-C<sub>4</sub> alkyl)<sub>2</sub> or C<sub>1</sub>-C<sub>4</sub> alkyl; and(j) -CO.R" where R" is H, halomethyl, -COO(C<sub>1</sub>-C<sub>4</sub> alkyl), -CH<sub>2</sub>O(C<sub>1</sub>-C<sub>4</sub> alkyl), -CH<sub>2</sub>CO(C<sub>1</sub>-C<sub>4</sub> alkyl), C<sub>1</sub>-C<sub>4</sub> alkyl, C<sub>1</sub>-C<sub>4</sub> alkoxy, aryl, heteroaryl, morpholino or 5-oxo-pyrrolidin-2-yl.The compounds have utility as anti-ischaemic and antihypertensive agents.
Patent NZ-207631-A (NZ)
Title: De-inking fibre stock or slurry using air bubbles
Inventor: NANDA A K
IPC: D21B1/32
Filed: 1984-03-26
Abstract: In a deinking process for a fibre stock or slurry air is introduced into the slurry so that air bubbles and ink come into contact, and the ink-laden bubbles are then separated from the slurry. 
<??>In order to provide an improved separation process the invention proposes to independently control the air injection, the mixing of the air and slurry, and the separation process by splitting them into separate steps so as to optimise the separation process. 
<??>Thus, there is provided a separation cell (31) which is fed with slurry from an inlet, an air inlet device, which in one embodiment comprises a porous sintered sleeve (7) to which air pressure is applied, and a mixing section which imposes turbulent flow on the air bubbles and slurry by passing the constituents through a series of turbulence discs (39). The resulting mixture enters the separation cell where the ink-laden bubbles rise to the surface as a foam which is conveniently removed by suction. The reinked slurry being drawn off from the separation cell.
Patent NZ-210666-A (NZ)
Title: Naphthalene derivatives and anti-psoriasis compositions
Inventor: JONES G H
IPC: C07C69/16
Filed: 1984-12-20
Abstract: Psoriasis in mammals is relieved by topically administering naphthalenes of the formula: <CHEM>  wherein: R<1> and R<2> are the same and are lower alkoxy, lower alkylthio, optionally substituted phenoxy or optionally substituted phenylthio, R<3> is lower alkyl, lower alkoxy, or halo and m is 0, 1 or 2 or R<3> is optionally substituted phenyl, optionaily substituted phenyl lower alkyl, optionally substituted phenyl lower alkoxy, amino, lower alkylamino, lower dialkylamino, cyano, or S(O)n R wherein R is lower alkyl; optionally substituted phenyl; optionally substituted phenyl lower alkyl; or optionally substituted heterocyclic aryl of three to nine ring atoms containing one or two heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, and the pharmaceutically acceptable acid addition salts thereof; and m is 1 and n is 0, 1 or 2; and W is alkyl of one to seven carbon atoms, optionally substituted phenyl or optionally substituted benzyl.
Patent NZ-211752-A (NZ)
Title: Method of reducing sweetness using phenylalkanoic acid salts
Inventor: LINDLEY M G
IPC: A23L27/20
Filed: 1985-04-11
Abstract: The sweetness of an ingestible product or oral composition containing a sweetening sugar or sugar alcohol in relatively large quantities can be reduced and/or the flavour enhanced by incorporation of at least one compound of the general formula (I)in which m represents 0 or 1, A represents a homocyclic or heterocyclic aromatic group with one or more rings; and B represents a hydrogen atom, a lower aliphatic group with 1-3 carbon atoms or a phenyl group; or, when m represents 0, A and B together represent a bivalent homocyclic or heterocyclic aromatic group with two or more rings, or a methylidene group carrying as a substituent a homocyclic or heterocyclic aromatic group with one or more rings; an aromatic ring of A, or of A and B together, optionally carrying one to three substituents selected from lower alkoxy groups, lower alkyl alkenyl groups, formyl or acetyl groups, hydroxy groups or acyloxy groups, and halogen atoms;C represents a hydrogen atom or an alkyl group or, when m represents 0, a hydroxy or alkoxy group;D represents an oxygen or sulphur atom;X<sup>+</sup> represents a hydrogen ion or another physiologically compatible cation;with the proviso that m represents 1 when S represents a substituted or unsubstituted phenyl group and Band C both represent hydrogen atoms; or when A represents an unsubstituted phenyl group, B represents an alkyl group and C represents a hydrogen atom.
Patent NZ-223646-A (NZ)
Title: Nedocromil calcium and pharmaceutical compositions
Inventor: NASSIM MICHAEL ARNOLD
IPC: C07D491/052
Filed: 1988-02-25
Abstract: There are described a new compound, methods for its preparation and compositions containing it. Calcium 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8 -dicarboxy late is a novel compound and is useful in the treatment of reversible obstructive airways disease and/or the prevention or treatment of rhinitis.
Patent NZ-226500-A (NZ)
Title: Optical oximeter: modulation of light sources
Inventor: HOOD RUSH W
IPC: A61B5/15
Filed: 1988-10-07
Abstract: A pulse oximeter is provided including two light (62, 64) emitting diodes. Each LED is energized by a unique modulation signal. Light produced by the LEDs passes through the tissue of a subject and is detected by a photodiode (60). The photodiode signal is separated by tuned circuits (72, 74) resonant at the two modulation signals frequencies and physiological information signals are recovered from the separated signals by amplitude demodulation (100, 102). The inventive arrangement provides identification of back-to-back coupled LEDs and narrow band filtering for good noise immunity.
Patent NZ-243348-A (NZ)
Title: Process for paper manufacture characterised by the addition to the stock of a polysaccharide or acrylamide-based polymer anionic retention agent together with an alkaline aluminate solution
Inventor: CARRE BRUNO
IPC: D21H17/24
Filed: 1992-06-29
Abstract: PCT No. PCT/SE92/00416 Sec. 371 Date Jan. 3, 1994 Sec. 102(e) Date Jan. 3, 1994 PCT Filed Jun. 12, 1992 PCT Pub. No. WO93/01352 PCT Pub. Date Jan. 21, 1993.A process for improved dewatering and retention in the manufacture of paper, where a retention agent containing anionic groups and being based on a polysaccharide or being an acrylamide-based polymer and an alkaline solution of an aluminate are added to the stock containing lignocellulose-containing fibres and optionally fillers. The pH of the stock prior to the addition of the aluminate should be below about 7 to obtain the desired cationic aluminum hydroxide complexes in the stock. The present process is cost effective and insensitive to the content of calcium in the white water.
Patent NZ-299279-A (NZ)
Title: Use of non-immunogenic tissue graft compositions derived from intestinal submucosa
Inventor: KNAPP PETER M
IPC: A61K35/38
Filed: 1993-11-10
Abstract: The use of a sheet of a first tissue graft composition comprising: a) tunica submucosa and basilar portions of the tunica mucosa, these portions being delaminated from the tunica muscularis and the luminal portion of the tunica mucosa of a segment of intestine of a warm blooded vertebrate; b) the sheet being formed into a sealed pouch and filled with a second tissue graft composition comprising comminuted intestinal tissue comprising tunica submucosa or protease digested intestinal tissue comprising tunica submuscosa; in the manufacture of a tissue graft construct for surgical reconstruction of a collagenous meniscus at the interface of articulating bones.
Patent NZ-320272-A (NZ)
Title: process for binding a lignocellulosic material to a polyisocyanate composition containing a metal carboxylate or alkoxide
Inventor: JUNG BRUNO ANDRE ALPHONSE
IPC: C08G18/64
Filed: 1996-10-18
Abstract: A process for binding lignocellulosic material is claimed comprising: a) bringing the lignocellulosic material in contact with a polyisocyanate composition and b) subsequently allowing the material to bind. The polyisocyanate material comprises an organic compound derived from a metal of group IVB of the periodic table of elements. The organic compound is a metal carboxylate or a metal alkoxide or a chelate complex with the metal as central atom and at least one polydenate ligand.
Patent NZ-329328-A (NZ)
Title: Paint stripper containing benzaldehyde or benzyl alcohol and an activator and a thickener
Inventor: LALLIER JEAN-PIERRE
IPC: C09D9/00
Filed: 1997-12-04
Abstract: A composition for stripping paints from a substrate, particularly paints and primers with a high degree of crosslinking e.g. epoxy, polyurethane and alkyd paints, consists of 50-80 pts. wt. water; 20-50 pts. wt. benzaldehyde and/or benzylic acid; 5-15 pts. wt. at least one activator selected from pure, and partially or totally neutralised formic acid; and 0.05-10 pts. wt. at least one thickener, acrylic thickener being used if benzylic acid is present without benzaldehyde. Preferably bases for partial or total neutralisation of formic acid are selected from ethanolamine, triethanolamine, ammonia, ethylenediamine, ammonium carbonate, and pyrrole. Thickener(s) are selected from acrylic thickeners, cellulose thickeners, and xanthane rubber.
Patent NZ-331299-A (NZ)
Title: Antibody variants with reduced affinity for a cell-surface antigen
Inventor: WALDMANN HERMAN
IPC: C12P21/08
Filed: 1997-02-20
Abstract: An antibody which is a modified version of a therapeutic antibody with affinity for a cell-surface antigen, the antibody having reduced affinity for the antigen compared with the therapeutic antibody as a result of a modification to the antibody molecule, wherein the antibody is capable of inducing immunological tolerance to the therapeutic antibody having an H or L chain of the therapeutic antibody paired with an L or H chain of an unrelated antibody. Further claimed is a method of producing the antibody where the cell line which expresses the antibody is maintained. This antibody induces immunological tolerance in human beings or animals.
Patent NZ-331556-A (NZ)
Title: Parapoxviruses containing foreign DNA, their production and their use in vaccines
Inventor: SCHMEER NORBERT
IPC: A61K38/00
Filed: 1997-02-17
Abstract: Recombinant parapox virus being derived from parapox virus strain D1701 deposited under Reg No CNCM 1-751 and containing at least one insertion with the Hind III fragment 1 of parapox virus strain D 1701, said Hind III fragment having a size of about 5.6kbp for preparing a vaccine.
Patent NZ-333377-A (NZ)
Title: Polyamides that have a piperazine amide and/or substituted piperazine amide for removal of polyphenols from liquids with the help of protein removal agents like silica gel or tannin
Inventor: MICHOS DEMETRIUS
IPC: A23L2/80
Filed: 1997-06-10
Abstract: Amide-containing polymers characterised by the presence of piperazine amide and/or substituted piperazine amide in the polymer chain is used as adsorbents to remove polyphenolic compounds from liquids. The compositions are especially useful in combination with protein removal agents such as silica gel or tannin. The amide-containing polymer compositions (alone or in combination with protein removal agents) are especially useful in the stabilisation and/or chill proofing of plant derived liquids or beverages such as beer, wine, fruit juice and vegetable juice.